These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 2479229)
1. Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft. Siena S; Bregni M; Formosa A; Brando B; Lappi DA; Bonadonna G; Gianni AM J Biol Regul Homeost Agents; 1989; 3(2):84-8. PubMed ID: 2479229 [TBL] [Abstract][Full Text] [Related]
2. Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans. Siena S; Bregni M; Formosa A; Brando B; Marenco P; Lappi DA; Bonadonna G; Gianni AM Cancer Res; 1989 Jun; 49(12):3328-32. PubMed ID: 2785850 [TBL] [Abstract][Full Text] [Related]
3. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates. Siena S; Lappi DA; Bregni M; Formosa A; Villa S; Soria M; Bonadonna G; Gianni AM Blood; 1988 Aug; 72(2):756-65. PubMed ID: 3042047 [TBL] [Abstract][Full Text] [Related]
5. In vitro effects of an immunotoxin reactive with a shared B and T cell activation antigen. Harris P; Reed E; Suciu-Foca N Transplant Proc; 1991 Feb; 23(1 Pt 1):309-10. PubMed ID: 1990539 [No Abstract] [Full Text] [Related]
6. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688 [TBL] [Abstract][Full Text] [Related]
7. An immunotoxin made up with campath 1 and saporin 6: preliminary "in vitro" experience. Gobbi M; Barbieri L; Tazzari PL; Dinota A; Bontadini A; Rizzi S; Pession A; Stirpe F; Tura S J Exp Pathol; 1987; 3(4):359-62. PubMed ID: 3331647 [No Abstract] [Full Text] [Related]
8. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells. Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantation. Siena S; Bregni M; Formosa A; Martineau D; Lappi DA; Bonadonna G; Gianni AM Transplantation; 1988 Nov; 46(5):747-53. PubMed ID: 3264092 [TBL] [Abstract][Full Text] [Related]
10. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. Uckun FM; Ramakrishnan S; Houston LL J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433 [TBL] [Abstract][Full Text] [Related]
11. CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia. Bolognesi A; Polito L; Farini V; Bortolotti M; Tazzari PL; Ratta M; Ravaioli A; Horenstein AL; Stirpe F; Battelli MG; Malavasi F J Biol Regul Homeost Agents; 2005; 19(3-4):145-52. PubMed ID: 16602630 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells. Piselli P; Vendetti S; Poccia F; Cicconi R; Mattei M; Bolognesi A; Stirpe F; Colizzi V J Biol Regul Homeost Agents; 1995; 9(2):55-62. PubMed ID: 9127634 [TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection. Wagrowska-Danilewicz M; Danilewicz M Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789 [TBL] [Abstract][Full Text] [Related]
14. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin. Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858 [TBL] [Abstract][Full Text] [Related]
15. Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model. Tazzari PL; Polito L; Bolognesi A; Pistillo MP; Capanni P; Palmisano GL; Lemoli RM; Curti A; Biancone L; Camussi G; Conte R; Ferrara GB; Stirpe F J Immunol; 2001 Oct; 167(8):4222-9. PubMed ID: 11591743 [TBL] [Abstract][Full Text] [Related]
16. Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice. Flavell DJ; Warnes SL; Noss AL; Flavell SU Br J Cancer; 2000 Dec; 83(12):1755-61. PubMed ID: 11104577 [TBL] [Abstract][Full Text] [Related]
17. 192IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei. Rossner S; Härtig W; Schliebs R; Brückner G; Brauer K; Perez-Polo JR; Wiley RG; Bigl V J Neurosci Res; 1995 Jun; 41(3):335-46. PubMed ID: 7563226 [TBL] [Abstract][Full Text] [Related]
18. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia. Flavell DJ; Warnes S; Noss A; Flavell SU Cancer Res; 1998 Dec; 58(24):5787-94. PubMed ID: 9865737 [TBL] [Abstract][Full Text] [Related]
19. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462 [TBL] [Abstract][Full Text] [Related]
20. Selective killing of CD4+ and CD8+ cells with immunotoxins containing saporin. Barbieri L; Bolognesi A; Dinota A; Lappi DA; Soria M; Tazzari PL; Stirpe F Scand J Immunol; 1989 Sep; 30(3):369-72. PubMed ID: 2571186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]